TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.20$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ZYBT
Line item 2021 2022 2023 2024 2025
– +21.6% -18.7% -12.0% -37.6%
– +20.4% -23.4% +16.2% -2.7%
– +22.4% -15.4% -29.7% -73.9%
– +18.1% -11.3% +7.5% +40.8%
– +30.1% -10.7% +146.6% -51.4%
– +20.1% -3.2% +99.3% -45.5%
– +25.7% -31.7% -61.8% -497.5%
– +171.4% +55.8% -8.6% -15.9%
– +20.4% -31.5% -67.1% -599.3%
– +23.8% -23.5% – –
– +20.0% -32.7% -64.0% -717.0%
– +22.0% -15.7% – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?